Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -22.18%-460.87K | -136.00%-198.27K | 32.04%-349.41K | 44.37%-1.35M | -375.63K | 66.97%-377.21K | 93.27%-84.01K | -514.15K | -7.41%-2.43M | -451.05%-1.14M |
| Net income from continuing operations | 98.54%-495.42K | 48.36%-238.05K | 28.19%-401.27K | -972.46%-35.79M | ---868.66K | -19,307.26%-33.91M | -215.28%-460.96K | ---558.82K | 4.09%-3.34M | 114.13%176.52K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.11K | --1.54K |
| Depreciation and amortization | --0 | --0 | -99.18%13 | -20.03%3.16K | --124 | --449 | --1.01K | --1.58K | --3.95K | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | --33.24M | --486.89K | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | -89.46%31.15K | -52.24%41.92K | -20.66%42.31K | -71.86%531.67K | --95.04K | 68.07%295.52K | -52.12%87.78K | --53.34K | 380.68%1.89M | 154.66%175.83K |
| Deferred tax | ---- | --0 | --0 | --0 | --0 | --13K | ---102K | --89K | --51K | ---- |
| Other non cashItems | ---- | ---- | ---- | 137.88%508.88K | --0 | ---- | ---- | ---- | ---1.34M | ---895.43K |
| Change In working capital | 108.53%3.4K | -100.55%-2.14K | 109.60%9.53K | -47.16%161.98K | ---89.03K | 94.01%-39.91K | 152.07%390.17K | ---99.25K | 180.22%306.54K | -1,140.84%-666.45K |
| -Change in receivables | 172.52%4.21K | -106.75%-7.57K | -91.17%4.46K | -56.50%205.96K | --49.06K | 98.59%-5.81K | 206.45%112.19K | --50.52K | 624.03%473.44K | -2,970.07%-412.19K |
| -Change in prepaid assets | 405.97%12.96K | -146.91%-7.16K | -66.36%20.24K | 159.95%73.56K | ---4.43K | 219.78%2.56K | 103.80%15.26K | --60.16K | 59.83%-122.7K | -119.07%-2.14K |
| -Change in payables and accrued expense | 62.45%-13.77K | -95.21%12.58K | 79.08%-43.92K | -984.22%-117.54K | ---133.66K | -155.94%-36.67K | 251.15%262.72K | ---209.93K | -3.00%13.29K | -121.63%-14.33K |
| -Change in other current assets | --0 | --0 | --28.75K | --0 | --0 | --0 | ---- | ---- | ---57.5K | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---180.3K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -22.18%-460.87K | -136.00%-198.27K | 32.04%-349.41K | 44.37%-1.35M | ---375.63K | 66.97%-377.21K | 93.27%-84.01K | ---514.15K | -7.41%-2.43M | -451.05%-1.14M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 94.85%-26.57K | 102.83%25.65K | 93.14%-80.97K | 54.27%-2.84M | -238.56K | 82.77%-515.79K | 29.62%-904.86K | -1.18M | -5,547.20%-6.21M | -2.99M |
| Net PPE purchase and sale | --0 | --0 | --0 | 37.13%-12.3K | --0 | --0 | --0 | ---12.3K | ---19.56K | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | --2.65M | --0 |
| Net other investing changes | 94.85%-26.57K | 102.83%25.65K | 93.07%-80.97K | 68.03%-2.83M | ---238.56K | 82.70%-515.79K | 12.58%-904.86K | ---1.17M | -7,941.45%-8.84M | ---2.98M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 94.85%-26.57K | 102.83%25.65K | 93.14%-80.97K | 54.27%-2.84M | ---238.56K | 82.77%-515.79K | 29.62%-904.86K | ---1.18M | -5,547.20%-6.21M | ---2.99M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.3M | -100.80%-17.62K | -8.25K | -80.62%2.19M | 0 | 0 | 155,244.33%2.19M | 0 | 509.98%11.3M | -100.00%-1 |
| Net common stock issuance | --1.3M | ---- | ---- | -81.38%2.28M | --0 | --0 | ---- | ---- | 1,039.44%12.22M | --3.18M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.74%2K | -4,343.33%-3.18M |
| Net other financing activities | ---787 | ---17.62K | ---8.25K | 90.83%-84.36K | --0 | --0 | ---- | ---- | ---919.53K | ---1 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --1.3M | -100.80%-17.62K | ---8.25K | -80.62%2.19M | --0 | --0 | 155,244.33%2.19M | --0 | 509.98%11.3M | -100.00%-1 |
| Net cash flow | ||||||||||
| Beginning cash position | -89.65%246.67K | -63.00%436.92K | -69.56%875.56K | 1,248.83%2.88M | --1.49M | -73.50%2.38M | -89.75%1.18M | --2.88M | -70.84%213.23K | 1,082.24%8.99M |
| Current changes in cash | 190.91%811.78K | -115.83%-190.25K | 74.12%-438.64K | -175.13%-2M | ---614.19K | 78.41%-893K | 147.41%1.2M | ---1.7M | 613.96%2.66M | -3,026.80%-4.14M |
| End cash Position | -28.95%1.06M | -89.65%246.67K | -63.00%436.92K | -69.56%875.56K | --875.56K | -69.32%1.49M | -73.50%2.38M | --1.18M | 1,248.83%2.88M | 672.88%4.86M |
| Free cash from | -22.18%-460.87K | -136.00%-198.27K | 33.63%-349.41K | 44.32%-1.36M | ---375.63K | 67.31%-377.21K | 93.27%-84.01K | ---526.45K | -8.28%-2.45M | -456.72%-1.15M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.